Monday, November 24, 2014

Selenium Slows Down Immuno-Response to Treat Melanoma, Prostate Cancer, and Types of Leukemia




By researching more about disease mechanisms that cause cancer in the skin and body, cancer can be fought by neutralizing these stimulants. New research about a Selenium compound (element naturally found in garlic and broccoli) that partook in the University of Copenhagen: The Faculty of Health and Medical Sciences (in a Journal of  Biological Chemistry) involving Selenium's cancer treating properties was written in this article. More specifically, the researchers found that a liquid form of NGK2D ligands (or tumor marker) can be seen to be neutralized by Selenium and therefore, slowing the cancer spread. This neutralization is helpful against Melanoma, Prostate Cancer, and Types of Leukemia because these types of cancer are a result of over expression by the immune system. By neutralizing the over-expression, these cancers can be effectively treated with future Selenium-type drugs.

However, this was not the first test in determining whether Selenium was effective in any cancer treatment because of its possible long term adverse effects by too much dosage over time and conflicting results in test studies. For example, three years ago, a study done through randomized controlled clinical trials showed that Selenium was not beneficial in blocking prostate cancer and had long term health complications. However, with this new discovery, Selenium can be taken to the next step into producing effective drugs.

I found this topic and articles very interesting because anything cancer treatment fascinates me because I'm living in the generation that has the high possibility of solving the problem of  many types of cancer. Knowing that better treatment like Selenium is out there to be exploited gives my mind comfort with the fact that humanity is one step closer to curing cancer completely.
Original Article: http://www.sciencedaily.com/releases/2014/11/141124125442.htm
Supporting Article: http://www.sciencedaily.com/releases/2011/05/110510211556.htm

No comments:

Post a Comment